The Prostacyclin Analog Beraprost Sodium Ameliorates Characteristics of Metabolic Syndrome in Obese Zucker (Fatty) Rats

OBJECTIVE: The prostacyclin analog, beraprost sodium (BPS), was examined for its potential to improve the symptoms of obesity-type diabetes (i.e., hyperglycemia, hyperinsulinemia, dyslipidemia, histopathologic changes, and diabetic complications). RESEARCH DESIGN AND METHODS: Obese Zucker rats, an e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Nahoko, Kaneko, Masayuki, Tamura, Mitsutaka, Kurumatani, Hajimu
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844818/
https://www.ncbi.nlm.nih.gov/pubmed/20068136
http://dx.doi.org/10.2337/db09-1432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844818/
https://www.ncbi.nlm.nih.gov/pubmed/20068136
http://dx.doi.org/10.2337/db09-1432

Ejemplares similares